1. Home
  2. NAOV vs SCNI Comparison

NAOV vs SCNI Comparison

Compare NAOV & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAOV
  • SCNI
  • Stock Information
  • Founded
  • NAOV 2003
  • SCNI 2003
  • Country
  • NAOV United States
  • SCNI Israel
  • Employees
  • NAOV N/A
  • SCNI N/A
  • Industry
  • NAOV Industrial Specialties
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NAOV Health Care
  • SCNI Health Care
  • Exchange
  • NAOV Nasdaq
  • SCNI Nasdaq
  • Market Cap
  • NAOV 2.4M
  • SCNI 2.3M
  • IPO Year
  • NAOV N/A
  • SCNI N/A
  • Fundamental
  • Price
  • NAOV $0.92
  • SCNI $2.05
  • Analyst Decision
  • NAOV
  • SCNI
  • Analyst Count
  • NAOV 0
  • SCNI 0
  • Target Price
  • NAOV N/A
  • SCNI N/A
  • AVG Volume (30 Days)
  • NAOV 3.0M
  • SCNI 102.4K
  • Earning Date
  • NAOV 08-13-2025
  • SCNI 08-14-2025
  • Dividend Yield
  • NAOV N/A
  • SCNI N/A
  • EPS Growth
  • NAOV N/A
  • SCNI N/A
  • EPS
  • NAOV N/A
  • SCNI N/A
  • Revenue
  • NAOV $2,662,000.00
  • SCNI $658,000.00
  • Revenue This Year
  • NAOV N/A
  • SCNI N/A
  • Revenue Next Year
  • NAOV N/A
  • SCNI N/A
  • P/E Ratio
  • NAOV N/A
  • SCNI N/A
  • Revenue Growth
  • NAOV N/A
  • SCNI N/A
  • 52 Week Low
  • NAOV $0.67
  • SCNI $1.90
  • 52 Week High
  • NAOV $16.25
  • SCNI $6.18
  • Technical
  • Relative Strength Index (RSI)
  • NAOV 40.36
  • SCNI 39.45
  • Support Level
  • NAOV $0.89
  • SCNI $2.10
  • Resistance Level
  • NAOV $1.08
  • SCNI $2.38
  • Average True Range (ATR)
  • NAOV 0.07
  • SCNI 0.15
  • MACD
  • NAOV 0.03
  • SCNI -0.01
  • Stochastic Oscillator
  • NAOV 52.29
  • SCNI 2.17

About NAOV NanoVibronix Inc.

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: